CA2078716A1 - Proteine de e. coli enterohemorragique de fixation et de destruction - Google Patents

Proteine de e. coli enterohemorragique de fixation et de destruction

Info

Publication number
CA2078716A1
CA2078716A1 CA 2078716 CA2078716A CA2078716A1 CA 2078716 A1 CA2078716 A1 CA 2078716A1 CA 2078716 CA2078716 CA 2078716 CA 2078716 A CA2078716 A CA 2078716A CA 2078716 A1 CA2078716 A1 CA 2078716A1
Authority
CA
Canada
Prior art keywords
sequence
seq
coli
dna segment
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2078716
Other languages
English (en)
Inventor
Joyce De Azavedo
James Brunton
Marie Louie
Glen Beebakhee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mount Sinai Hospital Corp
Original Assignee
Mount Sinai Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Hospital Corp filed Critical Mount Sinai Hospital Corp
Priority to CA 2078716 priority Critical patent/CA2078716A1/fr
Publication of CA2078716A1 publication Critical patent/CA2078716A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2078716 1992-09-21 1992-09-21 Proteine de e. coli enterohemorragique de fixation et de destruction Abandoned CA2078716A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2078716 CA2078716A1 (fr) 1992-09-21 1992-09-21 Proteine de e. coli enterohemorragique de fixation et de destruction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2078716 CA2078716A1 (fr) 1992-09-21 1992-09-21 Proteine de e. coli enterohemorragique de fixation et de destruction

Publications (1)

Publication Number Publication Date
CA2078716A1 true CA2078716A1 (fr) 1994-03-22

Family

ID=4150432

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2078716 Abandoned CA2078716A1 (fr) 1992-09-21 1992-09-21 Proteine de e. coli enterohemorragique de fixation et de destruction

Country Status (1)

Country Link
CA (1) CA2078716A1 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040177A1 (fr) * 1996-04-19 1997-10-30 Henry M. Jackson Foundation For The Advancement Of Military Medicine Procede de stimulation d'une reaction immunitaire par administration d'organismes hotes qui expriment l'intimine seule ou sous forme de proteine de fusion associee a un ou plusieurs antigenes
WO1997040161A1 (fr) * 1996-04-19 1997-10-30 Henry M. Jackson Foundation For The Advancement Of Military Medecine Intimine marquee a l'histidine et procedes d'utilisation de l'intimine pour stimuler une reaction immunitaire et en tant que porteur d'antigene a capacite de ciblage
WO1997040063A3 (fr) * 1996-04-23 1998-03-26 Univ British Columbia Proteine associee a un escherichia coli pathogene
EP0864657A1 (fr) * 1997-03-14 1998-09-16 Centre National d'Etudes Vétérinaires et Alimentaires CNEVA Oligonucléotides dérivés des gènes vts de bactéries E. coli productrices de vérotoxines et leurs utilisations
WO1999041614A2 (fr) * 1998-02-16 1999-08-19 Imperial College Of Science, Technology And Medicine Procedes
WO1999055908A2 (fr) * 1998-04-28 1999-11-04 Bio-Rad Pasteur Sequences nucleotidiques pour la detection des escherichia coli enterohemorragiques (ehec)
WO2001044456A2 (fr) * 1999-12-17 2001-06-21 The University Of Nottingham Modification de micro-organismes
WO2001066572A2 (fr) * 2000-03-10 2001-09-13 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) Polynucleotides de type b2/d+ a- et isoles d'e.coli, et applications biologiques de tels polynucleotides et leurs polypeptides
WO2001073440A2 (fr) * 2000-03-28 2001-10-04 Schebo Biotech Ag Detection de germes e.coli diarrhogenes
US6623737B2 (en) * 1995-03-23 2003-09-23 Imperial College Of Science, Technology & Medicine Antibodies to intimin-like proteins of E. coli
US6635259B2 (en) * 1997-03-21 2003-10-21 University Of Maryland, Baltimore Escherichia coli secreted protein B
US7208574B1 (en) 1997-11-12 2007-04-24 The University Of British Columbia Host receptor for pathogenic bacteria
US7445782B2 (en) * 2001-03-15 2008-11-04 Valorisation-Recherche, Societe En Commandite Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases
US7846435B1 (en) 1998-05-20 2010-12-07 Teijin Limited Humanized antibodies that recognize Verotoxin II and cell line producing same

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623737B2 (en) * 1995-03-23 2003-09-23 Imperial College Of Science, Technology & Medicine Antibodies to intimin-like proteins of E. coli
US6261561B1 (en) * 1996-04-19 2001-07-17 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
WO1997040161A1 (fr) * 1996-04-19 1997-10-30 Henry M. Jackson Foundation For The Advancement Of Military Medecine Intimine marquee a l'histidine et procedes d'utilisation de l'intimine pour stimuler une reaction immunitaire et en tant que porteur d'antigene a capacite de ciblage
WO1997040177A1 (fr) * 1996-04-19 1997-10-30 Henry M. Jackson Foundation For The Advancement Of Military Medicine Procede de stimulation d'une reaction immunitaire par administration d'organismes hotes qui expriment l'intimine seule ou sous forme de proteine de fusion associee a un ou plusieurs antigenes
US6942861B2 (en) * 1996-04-19 2005-09-13 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
US6881411B2 (en) 1996-04-19 2005-04-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
US6406885B1 (en) 1996-04-19 2002-06-18 Henry M. Jackson Foundation For The Advancement Of Military Medicine Plants and plant cells expressing histidine tagged intimin
US7214499B2 (en) 1996-04-23 2007-05-08 University Of British Columbia Pathogenic Escherichia coli associated protein
US6355254B1 (en) 1996-04-23 2002-03-12 University Of British Columbia Pathogenic Escherichia coli associated protein EspA
US8021861B2 (en) 1996-04-23 2011-09-20 University Of British Columbia Pathogenic Escherichia coli associated protein
WO1997040063A3 (fr) * 1996-04-23 1998-03-26 Univ British Columbia Proteine associee a un escherichia coli pathogene
US7078193B2 (en) 1996-04-23 2006-07-18 University Of British Columbia Pathogenic Escherichia coli associated protein espA
FR2760749A1 (fr) * 1997-03-14 1998-09-18 Veterinaires Et Alimentaires C Oligonucleotides derives des genes vts de bacteries e. coli productrices de verotoxines, et leurs utilisations
EP0864657A1 (fr) * 1997-03-14 1998-09-16 Centre National d'Etudes Vétérinaires et Alimentaires CNEVA Oligonucléotides dérivés des gènes vts de bactéries E. coli productrices de vérotoxines et leurs utilisations
US6635259B2 (en) * 1997-03-21 2003-10-21 University Of Maryland, Baltimore Escherichia coli secreted protein B
US7531315B2 (en) 1997-11-12 2009-05-12 The University Of British Columbia Method for detecting a host receptor for pathogenic bacteria
US7759462B2 (en) 1997-11-12 2010-07-20 University Of British Columbia Host receptor for pathogenic bacteria
US7208574B1 (en) 1997-11-12 2007-04-24 The University Of British Columbia Host receptor for pathogenic bacteria
WO1999041614A3 (fr) * 1998-02-16 1999-10-07 Imperial College Procedes
WO1999041614A2 (fr) * 1998-02-16 1999-08-19 Imperial College Of Science, Technology And Medicine Procedes
WO1999055908A3 (fr) * 1998-04-28 1999-12-29 Pasteur Sanofi Diagnostics Sequences nucleotidiques pour la detection des escherichia coli enterohemorragiques (ehec)
WO1999055908A2 (fr) * 1998-04-28 1999-11-04 Bio-Rad Pasteur Sequences nucleotidiques pour la detection des escherichia coli enterohemorragiques (ehec)
US7846435B1 (en) 1998-05-20 2010-12-07 Teijin Limited Humanized antibodies that recognize Verotoxin II and cell line producing same
WO2001044456A2 (fr) * 1999-12-17 2001-06-21 The University Of Nottingham Modification de micro-organismes
WO2001044456A3 (fr) * 1999-12-17 2001-12-27 Univ Nottingham Modification de micro-organismes
WO2001066572A3 (fr) * 2000-03-10 2003-05-01 Inst Nat Sante Rech Med Polynucleotides de type b2/d+ a- et isoles d'e.coli, et applications biologiques de tels polynucleotides et leurs polypeptides
WO2001066572A2 (fr) * 2000-03-10 2001-09-13 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) Polynucleotides de type b2/d+ a- et isoles d'e.coli, et applications biologiques de tels polynucleotides et leurs polypeptides
WO2001073440A3 (fr) * 2000-03-28 2002-05-30 Schebo Biotech Ag Detection de germes e.coli diarrhogenes
WO2001073440A2 (fr) * 2000-03-28 2001-10-04 Schebo Biotech Ag Detection de germes e.coli diarrhogenes
US7445782B2 (en) * 2001-03-15 2008-11-04 Valorisation-Recherche, Societe En Commandite Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases
US7727531B2 (en) * 2001-03-15 2010-06-01 Valorisation-Recherche, Societe En Commandite Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases
US8623372B2 (en) 2001-03-15 2014-01-07 Valorisation-Recherche, Societe En Commandite Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases

Similar Documents

Publication Publication Date Title
Kroll et al. Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export
CN1774447B (zh) 肺炎链球菌抗原
Wieler et al. Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes
Jones et al. A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGS cells
CA2078716A1 (fr) Proteine de e. coli enterohemorragique de fixation et de destruction
CN101684148A (zh) 脑膜炎奈瑟氏球菌的新表面蛋白
JPH08196283A (ja) ウレアーゼ活性を有するタンパク質をコードするヌクレオチド配列
Guerry et al. Development and characterization of recA mutants of Campylobacter jejuni for inclusion in attenuated vaccines
JP2008067707A (ja) 分類不可能なハエモフィルスインフルエンザエのｌｋｐピリン構造遺伝子およびオペロン
JPH03503837A (ja) 公衆衛生、医学、および獣医学の実施におけるマイコバクテリアのための診断法およびワクチン
JPH08509873A (ja) ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
TWI328035B (en) Anti-bacterial vaccine compositions
US6268171B1 (en) Recombinant PilC proteins, methods for producing them and their use
DK175831B1 (da) Neisseria gonorrhoeae-relaterede nucleinsyrer, rekombinantvektorer, værtsorgaismer, encellede organismer, polypeptidfremstillingsmetoder, polypeptidsammensætninger, vaccinepræparater, DNA-sonder, påvisningsmetoder og diagnostiske prövesæt, .........
WO1996002648A9 (fr) Operon et genes de structure de piline de lkp de haemophilus influenzae inclassables
Motin et al. The difference in the IcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains
US20090298713A1 (en) Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides
WO2001066572A9 (fr) Polynucleotides de type b2/d+ a- et isoles d'e.coli, et applications biologiques de tels polynucleotides et leurs polypeptides
US6156546A (en) Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter coli and Campylobacter jejuni
JP2002320494A (ja) 特にグラム陽性バクテリアのグリコペプタイドに対する抵抗力の発現に係るポリペプタイド、ポリペプタイドをコードするヌクレオチドシーケンスおよび診断への使用
JPH10507902A (ja) Ｒｏｃｈａｌｉｍａｅａ ｈｅｎｓｅｌａｅおよびｒｏｃｈａｌｉｍａｅａ ｑｕｉｎｔａｎａの核酸ならびにｒｏｃｈａｌｉｍａｅａ ｈｅｎｓｅｌａｅおよびｒｏｃｈａｌｉｍａｅａ ｑｕｉｎｔａｎａ感染を診断するための方法および組成物
JP2992980B2 (ja) 豚丹毒菌の莢膜欠損変異株 ｙｓ−１株
EP1080102A1 (fr) Antigenes et detection de ces antigenes
EP1058732A2 (fr) Attenuation de bacteries: matieres et methodes associees
WO1994013811A1 (fr) Nouveaux polypeptides, sequences d'acides nucleiques les codant, et leur utilisation pour empecher l'adhesion de bacteries a fimbriae f107

Legal Events

Date Code Title Description
FZDE Dead